RBM14
Gene Information
- Official Symbol: RBM14
- Official Name: RNA binding motif protein 14
- Aliases and Previous Symbols: N/A
- Entrez ID: 10432
- UniProt: Q96PK6
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: This gene encodes a ribonucleoprotein that functions as a general nuclear coactivator, and an RNA splicing modulator. This protein contains two RNA recognition motifs (RRM) at the N-terminus, and multiple hexapeptide repeat domain at the C-terminus that interacts with thyroid hormone receptor-binding protein (TRBP), and is required for transcription activation. Alternatively spliced transcript variants encoding different isoforms (with opposing effects on transcription) have been described for this gene. [provided by RefSeq, Oct 2011].
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| RRM 1 |
GO Terms
| glucocorticoid receptor signaling pathway |
| negative regulation of centriole replication |
| corticosteroid receptor signaling pathway |
| negative regulation of centrosome duplication |
| negative regulation of centrosome cycle |
| intracellular estrogen receptor signaling pathway |
| regulation of centriole replication |
| centriole assembly |
| mediator complex |
| negative regulation of organelle assembly |
| regulation of centrosome duplication |
| histone deacetylation |
| protein deacetylation |
| SMAD protein signal transduction |
| regulation of centrosome cycle |
| protein deacylation |
| macromolecule deacylation |
| nuclear receptor transcription coactivator activity |
| intracellular steroid hormone receptor signaling pathway |
| protein binding, bridging |
| transcription coregulator activity |
| microtubule organizing center organization |
| steroid hormone mediated signaling pathway |
| negative regulation of cytoskeleton organization |
| ribonucleoprotein complex |
| intracellular receptor signaling pathway |
| hormone-mediated signaling pathway |
| cellular response to steroid hormone stimulus |
| regulation of microtubule cytoskeleton organization |
| transmembrane receptor protein serine/threonine kinase signaling pathway |
| transcription factor complex |
| DNA replication |
| regulation of organelle assembly |
| DNA recombination |
| regulation of microtubule-based process |
| activation of innate immune response |
| negative regulation of cell cycle process |
| response to steroid hormone |
| positive regulation of innate immune response |
| positive regulation of response to biotic stimulus |
| histone modification |
| negative regulation of organelle organization |
| covalent chromatin modification |
| nuclear speck |
| regulation of innate immune response |
| positive regulation of defense response |
| microtubule cytoskeleton organization |
| DNA repair |
| positive regulation of multi-organism process |
| cellular response to lipid |
| regulation of response to biotic stimulus |
| regulation of cytoskeleton organization |
| cellular response to organic cyclic compound |
| negative regulation of cell cycle |
| positive regulation of response to external stimulus |
| cellular response to hormone stimulus |
| activation of immune response |
| microtubule-based process |
| chromatin organization |
| negative regulation of cellular component organization |
| enzyme linked receptor protein signaling pathway |
| DNA metabolic process |
| regulation of cell cycle process |
| organelle assembly |
| regulation of defense response |
| innate immune response |
| regulation of multi-organism process |
| cellular response to DNA damage stimulus |
| response to lipid |
| nucleolus |
| positive regulation of immune response |
| response to hormone |
| response to organic cyclic compound |
| defense response to other organism |
| regulation of cellular component biogenesis |
| chromosome organization |
| regulation of response to external stimulus |
| cytoskeleton organization |
| positive regulation of immune system process |
| regulation of immune response |
| regulation of cell cycle |
| positive regulation of transcription by RNA polymerase II |
| cellular response to endogenous stimulus |
| regulation of organelle organization |
| response to other organism |
| response to external biotic stimulus |
| response to biotic stimulus |
| defense response |
| RNA binding |
| response to endogenous stimulus |
| regulation of response to stress |
| positive regulation of transcription, DNA-templated |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| regulation of immune system process |
| cellular response to stress |
| cellular macromolecule biosynthetic process |
| positive regulation of RNA metabolic process |
| macromolecule biosynthetic process |
| immune response |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| MAD2L1 | 0.816 |
| MAD1L1 | 0.802 |
| BUB3 | 0.763 |
| KNTC1 | 0.746 |
| BUB1B | 0.72 |
| ZW10 | 0.72 |
| TRIP13 | 0.684 |
| MAD2L1BP | 0.655 |
| ZWILCH | 0.648 |
| FNTA | 0.574 |
| PELO | 0.532 |
| MARS | 0.506 |
| MED16 | 0.499 |
| DDX20 | 0.496 |
| RTCB | 0.494 |
| DPAGT1 | 0.493 |
| TBCA | 0.492 |
| GNB1L | 0.49 |
| CDC20 | 0.479 |
| FNTB | 0.471 |
| ALG1 | 0.465 |
| PAM16 | 0.464 |
| TRMT5 | 0.463 |
| SRP72 | 0.459 |
| UAP1 | 0.456 |
| RNMT | 0.456 |
| EPRS | 0.448 |
| NSMCE1 | 0.448 |
| TTI2 | 0.446 |
| DBR1 | 0.446 |
| DCTN6 | 0.446 |
| POLR3B | 0.444 |
| POLR3H | 0.443 |
| PMM2 | 0.44 |
| THG1L | 0.44 |
| PPP4C | 0.433 |
| GTF3C2 | 0.433 |
| GTF3C4 | 0.427 |
| AARS | 0.426 |
| DHPS | 0.425 |
| GFPT1 | 0.423 |
| OSGEP | 0.418 |
| ALG14 | 0.418 |
| RAD1 | 0.418 |
| SPCS2 | 0.418 |
| TTI1 | 0.417 |
| GEMIN5 | 0.416 |
| CDIPT | 0.415 |
| RABGGTB | 0.412 |
| HBS1L | 0.412 |
| VMP1 | 0.41 |
| HARS | 0.408 |
| TSEN54 | 0.407 |
| EIF4E | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 607/726
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 1/1 |
| bile duct | 24/28 |
| blood | 26/28 |
| bone | 22/25 |
| breast | 27/33 |
| central nervous system | 49/56 |
| cervix | 4/4 |
| colorectal | 15/17 |
| esophagus | 9/13 |
| fibroblast | 1/1 |
| gastric | 13/15 |
| kidney | 20/21 |
| liver | 15/20 |
| lung | 59/75 |
| lymphocyte | 12/14 |
| ovary | 21/26 |
| pancreas | 21/24 |
| peripheral nervous system | 12/16 |
| plasma cell | 14/15 |
| prostate | 1/1 |
| skin | 17/24 |
| soft tissue | 5/7 |
| thyroid | 1/2 |
| upper aerodigestive | 19/22 |
| urinary tract | 25/29 |
| uterus | 5/5 |
Essentiality in NALM6
- Essentiality Rank: 288
- Expression level (log2 read counts): 6.76
Expression Distribution
RBM14 Expression in NALM6 Cells: 6.76